SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-074104
Filing Date
2022-03-14
Accepted
2022-03-14 08:12:03
Documents
9
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d267980d20f.htm 20-F 2693674
2 EX-2.1 d267980dex21.htm EX-2.1 450091
3 EX-2.3 d267980dex23.htm EX-2.3 164604
4 EX-8.1 d267980dex81.htm EX-8.1 2636
5 EX-12.1 d267980dex121.htm EX-12.1 11083
6 EX-12.2 d267980dex122.htm EX-12.2 11128
7 EX-13.1 d267980dex131.htm EX-13.1 4764
8 EX-13.2 d267980dex132.htm EX-13.2 4487
9 EX-15.1 d267980dex151.htm EX-15.1 1356
  Complete submission text file 0001193125-22-074104.txt   3344969
Mailing Address DISCOVERY DRIVE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AX
Business Address DISCOVERY DRIVE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AX 44(0)1223696000
Abcam plc (Filer) CIK: 0001492074 (see all company filings)

IRS No.: 980487031 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-39633 | Film No.: 22735131
SIC: 2836 Biological Products, (No Diagnostic Substances)